Samin Saeed: My first time at ASCO

Samin Saeed, Chief Medical Officer at Random42 Scientific Communication, shared a post on LinkedIn:

“At the American Society of Clinical Oncology (ASCO) for the first time. Amazing to see the advancements in targeted therapies for solid tumors, and how much more precise oncologists can be in treating individual patients.

What strikes me however is the inconsistency in uptake, timing, and rapidity of molecular profiling in order to get the right treatment as early as possible. Definitely, an area industry, healthcare systems, and professional organizations can work on together to improve.”

Source: Samin Saeed/LinkedIn